Sabir, Z., khawar, M. M. H., Singh, S., Obaid, A. A., Heo, J., Mani, S., Prabusankar, S., Phan, K., Erambalur, S. S. V., Mandal, S., Seo, S., Abdurrahman, M. S., Khawar, M. (2026). Oral selective estrogen receptor degrader monotherapy versus standard endocrine therapy in estrogen receptor-positive, HER2-negative advanced breast cancer with ESR1 mutations: A meta-analysis of randomized trials.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13061